Calidi Biotherapeutics, Inc. Operating Lease Right-of-Use Assets
Calidi Biotherapeutics, Inc. (CLDI) had Operating Lease Right-of-Use Assets of $992.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-13
- 2026-06-30: Operating Lease, Right-of-Use Asset $992.00K.
- 2026-03-31: Operating Lease, Right-of-Use Asset $1.34M.
- 2025-12-31: Operating Lease, Right-of-Use Asset $1.68M.
- 2025-09-30: Operating Lease, Right-of-Use Asset $2.01M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-06-30 | $992.00K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $1.34M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $1.68M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $2.01M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $2.33M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $2.64M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $2.93M 10-K · filed 2026-03-27 |
| 2024-09-30 | $3.24M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $3.52M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $3.80M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $4.07M 10-K · filed 2025-03-31 |
| 2023-09-30 | $4.33M 10-Q · filed 2024-11-12 |
| 2023-06-30 | $4.58M 10-Q · filed 2024-08-13 |
| 2023-03-31 | $4.83M 10-Q · filed 2024-05-14 |
| 2022-12-31 | $199.00K 10-K · filed 2024-03-15 |
| 2022-09-30 | $193.00K 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |